OMED

OncoMed Pharmaceuticals, Inc.

OMED

Delisted

OMED was delisted on the 22nd of April, 2019.

68 hedge funds and large institutions have $65.1M invested in OncoMed Pharmaceuticals, Inc. in 2017 Q2 according to their latest regulatory filings, with 12 funds opening new positions, 18 increasing their positions, 26 reducing their positions, and 29 closing their positions.

Upgrade to unlock

New

Increased

Maintained

Reduced

Closed

more funds holding in top 10

Funds holding in top 10: →

less funds holding

Funds holding: →

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less capital invested

Capital invested by funds: $ → $

59% less first-time investments, than exits

New positions opened: 12 | Existing positions closed: 29

100% less call options, than puts

Call options by funds: $1K | Put options by funds: $222K

Holders

Holders Change

Holders Change %

% of All Funds

Holding in Top 10

Holding in Top 10 Change

Holding in Top 10 Change %

% of All Funds

New

Increased

Reduced

Closed

Calls

$1K

Puts

$222K

Net Calls

Net Calls Change

Top Buyers

1		+$12.1M
2		+$8.79M
3		+$954K
4	MWNA Marshall Wace North America New York	+$561K
5	Two Sigma Investments New York	+$439K

Top Sellers

1		-$9.08M
2		-$8.88M
3		-$3.04M
4	State Street Boston, Massachusetts	-$1.14M
5	Northern Trust Chicago, Illinois	-$651K

#	Name	Holding
76	76	–
77	77	–
78	78	–
79	79	–
80	80	–
81	81	–
82	82	–
83	83	–
84	84	–
85	85	–
86	86	–
87	87	–
88	88	–
89	89	–
90	90	–
91	91	–
92	92	–
93	93	–
94	94	–
95	95	–
96	96	–

#	Name	Holding
76	76	–
77	77	–
78	78	–
79	79	–
80	80	–
81	81	–
82	82	–
83	83	–
84	84	–
85	85	–
86	86	–
87	87	–
88	88	–
89	89	–
90	90	–
91	91	–
92	92	–
93	93	–
94	94	–
95	95	–
96	96	–

#	Name	Holding
76	76	–
77	77	–
78	78	–
79	79	–
80	80	–
81	81	–
82	82	–
83	83	–
84	84	–
85	85	–
86	86	–
87	87	–
88	88	–
89	89	–
90	90	–
91	91	–
92	92	–
93	93	–
94	94	–
95	95	–
96	96	–

OncoMed Pharmaceuticals, Inc. OMED